These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
431 related items for PubMed ID: 20160714
1. Methylation status of genes in non-neoplastic mucosa from patients with ulcerative colitis-associated colorectal cancer. Garrity-Park MM, Loftus EV, Sandborn WJ, Bryant SC, Smyrk TC. Am J Gastroenterol; 2010 Jul; 105(7):1610-9. PubMed ID: 20160714 [Abstract] [Full Text] [Related]
2. MHC Class II alleles in ulcerative colitis-associated colorectal cancer. Garrity-Park MM, Loftus EV, Sandborn WJ, Bryant SC, Smyrk TC. Gut; 2009 Sep; 58(9):1226-33. PubMed ID: 19251712 [Abstract] [Full Text] [Related]
3. A Biomarker Panel to Detect Synchronous Neoplasm in Non-neoplastic Surveillance Biopsies from Patients with Ulcerative Colitis. Garrity-Park MM, Loftus EV, Bryant SC, Smyrk TC. Inflamm Bowel Dis; 2016 Jul; 22(7):1568-74. PubMed ID: 27135485 [Abstract] [Full Text] [Related]
4. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients]. Lakatos L, Mester G, Erdélyi Z, David G, Pandúr T, Balogh M, Fischer S, Vargha P, Lakatos PL. Orv Hetil; 2006 Jan 29; 147(4):175-81. PubMed ID: 16515026 [Abstract] [Full Text] [Related]
5. The study of methylation and single nucleotide polymorphisms of cancer-related genes in patients with early-stage ulcerative colitis. Chen HX, Yuan ZY, Wu KX, Liu C, Mao QD, He BG, Yuan H. Scand J Gastroenterol; 2019 Apr 29; 54(4):427-431. PubMed ID: 31046486 [Abstract] [Full Text] [Related]
6. Epigenetic control of the E-cadherin gene (CDH1) by CpG methylation in colectomy samples of patients with ulcerative colitis. Azarschab P, Porschen R, Gregor M, Blin N, Holzmann K. Genes Chromosomes Cancer; 2002 Oct 29; 35(2):121-6. PubMed ID: 12203775 [Abstract] [Full Text] [Related]
7. Aberrant methylation of the HPP1 gene in ulcerative colitis-associated colorectal carcinoma. Sato F, Shibata D, Harpaz N, Xu Y, Yin J, Mori Y, Wang S, Olaru A, Deacu E, Selaru FM, Kimos MC, Hytiroglou P, Young J, Leggett B, Gazdar AF, Toyooka S, Abraham JM, Meltzer SJ. Cancer Res; 2002 Dec 01; 62(23):6820-2. PubMed ID: 12460892 [Abstract] [Full Text] [Related]
8. Tumor necrosis factor-alpha polymorphisms in ulcerative colitis-associated colorectal cancer. Garrity-Park MM, Loftus EV, Bryant SC, Sandborn WJ, Smyrk TC. Am J Gastroenterol; 2008 Feb 01; 103(2):407-15. PubMed ID: 18289203 [Abstract] [Full Text] [Related]
9. Aberrant crypt foci as precursors of the dysplasia-carcinoma sequence in patients with ulcerative colitis. Kukitsu T, Takayama T, Miyanishi K, Nobuoka A, Katsuki S, Sato Y, Takimoto R, Matsunaga T, Kato J, Sonoda T, Sakamaki S, Niitsu Y. Clin Cancer Res; 2008 Jan 01; 14(1):48-54. PubMed ID: 18172251 [Abstract] [Full Text] [Related]
10. Aberrant gene methylation in non-neoplastic mucosa as a predictive marker of ulcerative colitis-associated CRC. Scarpa M, Scarpa M, Castagliuolo I, Erroi F, Kotsafti A, Basato S, Brun P, D'Incà R, Rugge M, Angriman I, Castoro C. Oncotarget; 2016 Mar 01; 7(9):10322-31. PubMed ID: 26862732 [Abstract] [Full Text] [Related]
11. RUNX3 promoter methylation in colorectal cancer: its relationship with microsatellite instability and its suitability as a novel serum tumor marker. Nishio M, Sakakura C, Nagata T, Komiyama S, Miyashita A, Hamada T, Kuryu Y, Ikoma H, Kubota T, Kimura A, Nakanishi M, Ichikawa D, Fujiwara H, Okamoto K, Ochiai T, Kokuba Y, Sonoyama T, Ida H, Ito K, Chiba T, Ito Y, Otsuji E. Anticancer Res; 2010 Jul 01; 30(7):2673-82. PubMed ID: 20682997 [Abstract] [Full Text] [Related]
12. Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis. Rubin DT, LoSavio A, Yadron N, Huo D, Hanauer SB. Clin Gastroenterol Hepatol; 2006 Nov 01; 4(11):1346-50. PubMed ID: 17059900 [Abstract] [Full Text] [Related]
13. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions. Zou XP, Zhang B, Zhang XQ, Chen M, Cao J, Liu WJ. Hum Pathol; 2009 Nov 01; 40(11):1534-42. PubMed ID: 19695681 [Abstract] [Full Text] [Related]
14. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis? Rubin DT, Rothe JA, Hetzel JT, Cohen RD, Hanauer SB. Gastrointest Endosc; 2007 Jun 01; 65(7):998-1004. PubMed ID: 17451704 [Abstract] [Full Text] [Related]
15. Rare CpG island methylator phenotype in ulcerative colitis-associated neoplasias. Konishi K, Shen L, Wang S, Meltzer SJ, Harpaz N, Issa JP. Gastroenterology; 2007 Apr 01; 132(4):1254-60. PubMed ID: 17408633 [Abstract] [Full Text] [Related]
16. Prediction of colorectal neoplasia by quantitative methylation analysis of estrogen receptor gene in nonneoplastic epithelium from patients with ulcerative colitis. Tominaga K, Fujii S, Mukawa K, Fujita M, Ichikawa K, Tomita S, Imai Y, Kanke K, Ono Y, Terano A, Hiraishi H, Fujimori T. Clin Cancer Res; 2005 Dec 15; 11(24 Pt 1):8880-5. PubMed ID: 16361578 [Abstract] [Full Text] [Related]
17. Predicting ulcerative colitis-associated colorectal cancer using reverse-transcription polymerase chain reaction analysis. Watanabe T, Kobunai T, Yamamoto Y, Ikeuchi H, Matsuda K, Ishihara S, Nozawa K, Iinuma H, Kanazawa T, Tanaka T, Yokoyama T, Konishi T, Eshima K, Ajioka Y, Hibi T, Watanabe M, Muto T, Nagawa H. Clin Colorectal Cancer; 2011 Jun 15; 10(2):134-41. PubMed ID: 21859567 [Abstract] [Full Text] [Related]
18. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers. Yanagawa N, Tamura G, Oizumi H, Kanauchi N, Endoh M, Sadahiro M, Motoyama T. Lung Cancer; 2007 Oct 15; 58(1):131-8. PubMed ID: 17606310 [Abstract] [Full Text] [Related]
19. Immunohistochemical expression of P53 and oncogenes in ulcerative colitis-associated colorectal carcinoma. Brüwer M, Schmid KW, Senninger N, Schürmann G. World J Surg; 2002 Mar 15; 26(3):390-6. PubMed ID: 11865380 [Abstract] [Full Text] [Related]
20. Myeloperoxidase immunohistochemistry as a measure of disease activity in ulcerative colitis: association with ulcerative colitis-colorectal cancer, tumor necrosis factor polymorphism and RUNX3 methylation. Garrity-Park M, Loftus EV, Sandborn WJ, Smyrk TC. Inflamm Bowel Dis; 2012 Feb 15; 18(2):275-83. PubMed ID: 21425209 [Abstract] [Full Text] [Related] Page: [Next] [New Search]